Latest News
Conference Coverage
MedPAC mulls boost to payments for E&M visits
WASHINGTON – The commissioners debated whether the pay boost would make a difference.
From the Journals
Insights revealed into rheumatologist-patient discussions about biologics
An ethnographic, observational study analyzes discussions between rheumatologists and patients about starting biologics.
From the Journals
Menopause accelerates RA functional decline
Findings were based on surveys of over 8,000 women.
From the Journals
Turmeric-, frankincense-derived supplement shows OA benefit
The combination beat placebo in a randomized, controlled trial from Armenia.
Feature
Expert advice for the corporate titans taking on health care
Amazon, Berkshire Hathaway, and JPMorgan Chase & Co. want to disrupt health care.
Latest News
Health care gets little attention in State of the Union address
It’s anyone’s guess as to how Mr. Trump might lower drug costs.
Feature
Alex Azar confirmed as HHS Secretary
Democrats on the Senate Finance Committee challenged Mr. Azar on drug prices and other issues.
Feature
Doctors to Congress: Keep Part B drug payments out of MIPS adjustment
Certain specialists stand to lose significant Medicare pay under the current policy.
From the Journals
Checkpoint inhibitors look safe in rheumatology patients
The Mayo Clinic analysis examines 16 patients with rheumatologic diseases and cancer who received checkpoint inhibitor therapy.
Feature
Major medical, insurance, health groups agree on pre-auth improvement areas
Major hospital and health insurance groups, along with the AMA and APhA, agree on a statement of areas where the prior authorization process can...
Latest News
Lower residual RA activity after initial ETN-MTX, better remission chance
Check out the four predictive factors.